How the R&D Tax Credit for Businesses Turns Everyday Problem-Solving Into Tax Savings

The R&D tax credit for businesses is one of the most valuable dollar-for-dollar tax incentives the federal government offers, and most companies that qualify don’t claim it. The reason is simple: they don’t think what they do counts as “research.” But the IRS definition is far broader than most business owners realize. If your team has ever tested a new method, evaluated alternative materials or engineered a workaround to a technical problem, you may already be sitting on unclaimed credits worth tens of thousands of dollars.

The IRS Four-Part Test Is Easier To Pass Than You Think

Under IRC Section 41, a business activity qualifies as research when it meets four criteria.

1. The work must be technological in nature, relying on engineering, computer science or applied physical sciences. 
2. It must aim to eliminate uncertainty about a design, method or capability. 
3. The company must use a process of experimentation, meaning it evaluated one or more alternatives. 
4. And the activity must be directed at developing a new or improved product, process, technique or formula.

That sounds like it belongs in a lab. In practice, it describes work that happens every day across manufacturing floors, construction sites, healthcare facilities and technology firms. A manufacturer redesigning a production line to reduce scrap rates or testing a new alloy for heat resistance qualifies. A general contractor engineering a shoring system for unstable soil conditions or a mechanical subcontractor optimizing refrigerant piping layouts through iterative modeling qualifies. A healthcare organization developing custom EHR integrations, building patient portal software or designing clinical workflow improvements qualifies. A technology company writing algorithms to solve data architecture challenges or building automation tools qualifies. The common thread isn’t the industry. It’s whether the work involved technical uncertainty and a systematic process for resolving it.

What the OBBBA Changed and Why It Matters Now

The One Big Beautiful Bill Act (OBBBA), signed on July 4, 2025, created Section 174A, which permanently restores immediate expensing for domestic R&D costs. For tax years beginning after December 31, 2024, businesses can fully deduct qualifying domestic research expenditures in the year they’re incurred. That reverses the Tax Cuts and Jobs Act’s (TCJA) five-year amortization requirement, which had been squeezing cash flow for R&D-heavy companies since 2022.

The relief is retroactive for qualifying small businesses. Companies with average annual gross receipts of $31 million or less can amend their 2022, 2023 and 2024 returns to fully expense previously capitalized domestic R&D costs, potentially generating significant refunds, as outlined in IRS Rev. Proc. 2025-28. Larger businesses can’t amend prior returns, but they can accelerate remaining unamortized balances from 2022 through 2024, deducting them in full in 2025 or splitting them across 2025 and 2026.

The OBBBA also restored the pre-TCJA coordination between the R&D credit and the R&D deduction under Section 280C. Businesses claiming the full credit must now reduce their deductible R&D expenses by the credit amount, or they can elect the reduced credit (approximately 79% of the gross credit at the current 21% corporate rate) and keep the full deduction. That election must be made on a timely filed return. Combined, these changes make the R&D credit significantly more valuable than it’s been in years.

How the Credit Calculation Works

The math is more accessible than most companies expect. Three categories of spending generate qualified research expenses (QREs): 

1. Wages for employees who perform, directly supervise or directly support qualified research
2. Supplies consumed during experimentation
3. Contract research expenses, which are capped at 65% of amounts paid to outside contractors for qualified research (75% for qualified research consortia)

Here’s a simplified example. A $30 million manufacturing company employs 15 engineers and technical staff with combined W-2 wages of $1.8 million. After an R&D study, 40% of their time is determined to qualify, producing $720,000 in qualified wage expenses. Add $45,000 in qualifying supplies and $30,000 in qualifying contract research expenses, and total QREs come to roughly $795,000. Using the alternative simplified credit method at 14% of QREs above the base amount, the resulting federal credit could exceed $50,000. For companies operating in multiple states, state-level R&D credits can add meaningfully to that total. Qualified small businesses with less than $5 million in gross receipts can also apply up to $500,000 of their R&D credit against payroll taxes annually, even without income tax liability.

Documentation Is Where Most R&D Credits Fail

Starting with tax year 2026, the IRS requires most filers to complete Section G of Form 6765, which mandates business-component-level reporting. That means identifying each product, process or software project that generated QREs, describing the technical uncertainty and alternatives evaluated and breaking down expenses by category for each component. Companies with total QREs of $1.5 million or less and gross receipts under $50 million may file Section G optionally, but that exception is narrow.

The best practice is to track qualifying activities in real time: 

• Link project records to payroll data
• Tag experimentation hours by employee
• Document the technical questions your team was trying to answer. 

Reconstructing this information at year-end is expensive and produces weaker claims. Activities that don’t qualify include routine quality testing, cosmetic changes, research conducted outside the U.S., work performed after uncertainty has been resolved and third-party-funded research. Knowing where the line falls before you file is the difference between a defensible credit and an audit flag, which is why choosing the right R&D tax credit specialist matters.

Claim the Credit Your Innovation Has Already Earned

With full expensing restored, new reporting requirements in effect and retroactive relief deadlines approaching, 2026 is the year to get serious about your R&D tax strategy. Contact a James Moore professional to evaluate whether your business activities qualify and make sure you’re capturing every available credit.

All content provided in this article is for informational purposes only. Matters discussed in this article are subject to change. For up-to-date information on this subject please contact a James Moore professional. James Moore will not be held responsible for any claim, loss, damage or inconvenience caused as a result of any information within these pages or any information accessed through this site.